These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 9300240)

  • 1. Differential regulation of glomerular gelatinase B (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in obese Zucker rats.
    Schaefer L; Han X; August C; Matzkies F; Lorenz T; Schaefer RM
    Diabetologia; 1997 Sep; 40(9):1035-43. PubMed ID: 9300240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
    Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
    J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
    Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of doxycycline on the expression of matrix metalloproteinase and tissue inhibitor of MMP in myocardium after acute myocardial infarction: an animal experiment with rats].
    Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1288-93. PubMed ID: 15387968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
    Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
    Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of doxycycline, losartan, and their combination on the expression of matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, and collagen remodeling in the noninfarcted myocardium after acute myocardial infarction in rats].
    Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):53-61. PubMed ID: 15782494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of MMP-9 in mesangial cells and its changes in anti-GBM glomerulonephritis in WKY rats.
    Kuroda T; Yoshida Y; Kamiie J; Kovalenko P; Nameta M; Fujinaka H; Yaoita E; Endo T; Ishizuka S; Nakabayashi K; Yamada A; Nagasawa T; Yamamoto T
    Clin Exp Nephrol; 2004 Sep; 8(3):206-15. PubMed ID: 15480897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemia-reperfusion injury stimulates gelatinase expression and activity in kidney glomeruli.
    Caron A; Desrosiers RR; Langlois S; BĂ©liveau R
    Can J Physiol Pharmacol; 2005 Mar; 83(3):287-300. PubMed ID: 15870843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis.
    Tanney DC; Feng L; Pollock AS; Lovett DH
    Dev Dyn; 1998 Sep; 213(1):121-9. PubMed ID: 9733107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
    Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
    Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
    Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
    Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
    Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
    Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herbal medicine Sho-saiko-to (TJ-9) increases expression matrix metalloproteinases (MMPs) with reduced expression of tissue inhibitor of metalloproteinases (TIMPs) in rat stellate cell.
    Sakaida I; Hironaka K; Kimura T; Terai S; Yamasaki T; Okita K
    Life Sci; 2004 Mar; 74(18):2251-63. PubMed ID: 14987950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of matrix metalloproteinases during murine chorioallantoic placenta maturation.
    Teesalu T; Masson R; Basset P; Blasi F; Talarico D
    Dev Dyn; 1999 Mar; 214(3):248-58. PubMed ID: 10090151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
    Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
    Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements.
    Yokohama Y; Matsumoto T; Hirakawa M; Kuroki Y; Fujimoto N; Imai K; Okada Y
    Lab Invest; 1995 Dec; 73(6):899-911. PubMed ID: 8558853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.